Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
SLN.L Share News (SLN)
SLN Share
Price
SLN Share
News
SLN Share
Chat
SLN Share
Trades
SLN
Live RNS
SLN Share
Charts
SLN Broker
Ratings
SLN Directors
Deals
SLN Financial
Diary
SLN
Fundamentals
SLN Short
Positions
SLN
Media
SLN Company
Research
SLN Company
Timeline
- There is currently no data for SLN
SLN.L News
Silence Therapeutics to launch new trial before year end
(Sharecast News) - Silence Therapeutics said on Thursday that the first half of the year saw good progress in the development of its lead candidate, S...
UK Earnings, Trading Statements Calendar - Next 7 Days
Friday 6 September SIGHalf Year ResultsAshmore GroupFull Year Public Year Horizon Year 9
Silence Therapeutics Appoints Jorgen Wittendorff To New Senior Role
(Alliance News) - Silence Therapeutics PLC said Monday that it has appointed Jorgen Wittendorff to the new role of head of manufacturing.Wittendorff w...
Societe Generale Builds 5% Interest In Silence Therapeutics
(Alliance News) - Silence therapeutics PLC said on Thursday that French investment bank Societe Generale SA has a 5% stake in the company.It was not d...
Silence Therapeutics Appoints Mallinckrodt Executive Romano To Board
LONDON (Alliance News) - Silence Therapeutics PLC said Monday that Steven Romano has joined as non-executive director, as part of the company's collab...
Silence Therapeutics Surges As It Signs Major Deal With Mallinckrodt
(Alliance News) - New York-listed Mallinckrodt PLC has invested USD5 million into Silence Therapeutics PLC, the two announced on Thursday, as part of ...
UK Shareholder Meetings Calendar - Next 7 Days
Wednesday 19 JuneTarsus GroupCadongan PetroleumWhitbreadSagaN4 20
Silence Therapeutics enters into collaboration with Genomics England
(Sharecast News) - Novel therapeutics developer Silence Therapeutics has entered into a collaboration with Genomics England for the investigation of n...
Follow the stocks
